Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome - PubMed

Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome - PubMed

Risk of Cancer in Family Members of Patients with Lynch-Like Syndrome

María Dolores Picó 1, Ana Beatriz Sánchez-Heras 2, Adela Castillejo 3, Mar Giner-Calabuig 4, Miren Alustiza 4, Ariadna Sánchez 5, Leticia Moreira 5, María Pellise 5, Antoni Castells 5, Gemma Llort 6, Carmen Yagüe 6, Teresa Ramon Y Cajal 7, Alexandra Gisbert-Beamud 7, Joaquin Cubiella 8, Laura Rivas 8, Maite Herraiz 9, Catalina Garau 10, Inmaculada Salces 11, Marta Carrillo-Palau 12, Luis Bujanda 13, Adriá López-Fernández 14, Cristina Alvarez-Urturi 15, María Jesús López 16, Cristina Alenda 17, Pedro Zapater 18, Francisco Javier Lacueva 19, Francesc Balaguer 5, Jose-Luis Soto 3, Óscar Murcia 4, Rodrigo Jover 4

Affiliations 

• PMID: 32784934
 
• DOI: 10.3390/cancers12082225

Abstract

Lynch syndrome (LS) is a common cause of hereditary colorectal cancer (CRC). Some CRC patients develop mismatch repair deficiency without germline pathogenic mutation, known as Lynch-like syndrome (LLS). We compared the risk of CRC in first-degree relatives (FDRs) in LLS and LS patients. LLS was diagnosed when tumors showed immunohistochemical loss of MSH2, MSH6, and PMS2; or loss of MLH1 with BRAF wild type; and/or no MLH1 methylation and absence of pathogenic mutation in these genes. CRC and other LS-related neoplasms were followed in patients diagnosed with LS and LLS and among their FDRs. Standardized incidence ratios (SIRs) were calculated for CRC and other neoplasms associated with LS among FDRs of LS and LLS patients. In total, 205 LS (1205 FDRs) and 131 LLS families (698 FDRs) had complete pedigrees. FDRs of patients with LLS had a high incidence of CRC (SIR, 2.08; 95% confidence interval (CI), 1.56-2.71), which was significantly lower than that in FDRs of patients with LS (SIR, 4.25; 95% CI, 3.67-4.90; p < 0.001). The risk of developing other neoplasms associated with LS also increased among FDR of LLS patients (SIR, 2.04; 95% CI, 1.44-2.80) but was lower than that among FDR of patients with LS (SIR, 5.01, 95% CI, 4.26-5.84; p < 0.001). FDRs with LLS have an increased risk of developing CRC as well as LS-related neoplasms, although this risk is lower than that of families with LS. Thus, their management should take into account this increased risk.

Keywords: colorectal cancer; genetic; risk; surveillance.

Similar articles

• Risk of cancer in cases of suspected lynch syndrome without germline mutation.

  Rodríguez-Soler M, Pérez-Carbonell L, Guarinos C, Zapater P, Castillejo A, Barberá VM, Juárez M, Bessa X, Xicola RM, Clofent J, Bujanda L, Balaguer F, Reñé JM, de-Castro L, Marín-Gabriel JC, Lanas A, Cubiella J, Nicolás-Pérez D, Brea-Fernández A, Castellví-Bel S, Alenda C, Ruiz-Ponte C, Carracedo A, Castells A, Andreu M, Llor X, Soto JL, Payá A, Jover R.Gastroenterology. 2013 May;144(5):926-932.e1; quiz e13-4. doi: 10.1053/j.gastro.2013.01.044. Epub 2013 Jan 24.PMID: 23354017 Clinical Trial.
• Implication of DNA repair genes in Lynch-like syndrome.

  Xicola RM, Clark JR, Carroll T, Alvikas J, Marwaha P, Regan MR, Lopez-Giraldez F, Choi J, Emmadi R, Alagiozian-Angelova V, Kupfer SS, Ellis NA, Llor X.Fam Cancer. 2019 Jul;18(3):331-342. doi: 10.1007/s10689-019-00128-6.PMID: 30989425 Free PMC article.
• Prevalence of somatic mutl homolog 1 promoter hypermethylation in Lynch syndrome colorectal cancer.

  Moreira L, Muñoz J, Cuatrecasas M, Quintanilla I, Leoz ML, Carballal S, Ocaña T, López-Cerón M, Pellise M, Castellví-Bel S, Jover R, Andreu M, Carracedo A, Xicola RM, Llor X, Boland CR, Goel A, Castells A, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.Cancer. 2015 May 1;121(9):1395-404. doi: 10.1002/cncr.29190. Epub 2014 Dec 29.PMID: 25557234
• Current clinical topics of Lynch syndrome.

  Tanakaya K.Int J Clin Oncol. 2019 Sep;24(9):1013-1019. doi: 10.1007/s10147-018-1282-7. Epub 2018 May 9.PMID: 29744602 Review.
• Lynch Syndrome.

  Kohlmann W, Gruber SB.2004 Feb 5 [updated 2018 Apr 12]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.PMID: 20301390 Free Books & Documents. Review.